Bulgaria pitches fast domestic authorisation of innovative drugs to attract pharma firms

Bulgaria will rely on the speed and efficiency of its domestic authorisation procedures for innovative drug therapies to attract the interest of pharma companies to its small domestic market, the Ministry of Health told Euractiv.